| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/14/2008 | WO2008018447A1 Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 02/14/2008 | WO2008018427A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 02/14/2008 | WO2008018306A1 Quinazoline derivative |
| 02/14/2008 | WO2008018190A1 Fat-derived neural crest cells |
| 02/14/2008 | WO2008017886A1 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 02/14/2008 | WO2008017852A1 Diamine-containing, tetra- substituted piperazine compounds as melanocortin receptor modulators |
| 02/14/2008 | WO2008017752A2 Eucalyptus extract, method of preparation and therapeutic uses thereof |
| 02/14/2008 | WO2008017710A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 02/14/2008 | WO2008017491A1 Ligustilide derivatives for the treatment of disorders of the central nervous system |
| 02/14/2008 | WO2008017484A1 Novel agents for the treatment of disorders connected to impaired neurotransmission |
| 02/14/2008 | WO2008017465A1 Bicyclic lactam derivatives, their manufacture and use as pharmaceutical agents |
| 02/14/2008 | WO2008017280A1 Soporific; sedative containing myrrh and liquorice root |
| 02/14/2008 | WO2008017216A1 The application of marine steroid in preparing the medicine of treating neurons damaging |
| 02/14/2008 | WO2008002245A3 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 02/14/2008 | WO2008002244A3 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 02/14/2008 | WO2007146066A3 Novel piperazines, pharmaceutical compositions and methods of use thereof |
| 02/14/2008 | WO2007115975A3 USE OF kappa OPIOID RECEPTOR ANTAGONIST-CONTAINING COMPOSITIONS FOR THE TREATMENT OF DISSOCIATIVE DISORDERS |
| 02/14/2008 | WO2007106859A3 Phytonutrient compositions from mushrooms or filamentous fungi and methods of use |
| 02/14/2008 | WO2007089934A3 Methods of treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers |
| 02/14/2008 | WO2007088473A3 Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | WO2006024627A9 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/14/2008 | US20080039535 Methods of identifying agents for treating neurological disorders |
| 02/14/2008 | US20080039529 Adjunctive Therapy for Depression |
| 02/14/2008 | US20080039527 Calixarenes as Inhibitors of Protein Kinase B |
| 02/14/2008 | US20080039526 Compositions for promoting sleep |
| 02/14/2008 | US20080039510 (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics |
| 02/14/2008 | US20080039509 Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity |
| 02/14/2008 | US20080039502 e.g. N-[4-(4'-Methoxy-biphenyl-4-yloxymethyl)-5-methyl-furan-2-carbonyl]-benzenesulfonamide; prostaglandin E4 receptor antagonist; analgesic, antiinflammatory agent; migraines and headache |
| 02/14/2008 | US20080039498 Non-competitive NMDA receptor antagonists |
| 02/14/2008 | US20080039497 Use Of A Hydroximic Acid Halide Derivative In The Treatment Of Neurodegenerative Diseases |
| 02/14/2008 | US20080039496 Method of Modulating Neurite Outgrowth by the use of a Galanin-3 Receptor Antagonist |
| 02/14/2008 | US20080039478 Bicycloheteroaryl Compounds as P2X7 Modulators and Uses Thereof |
| 02/14/2008 | US20080039476 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/14/2008 | US20080039469 3-Benzyl-3a-cyclobutyl-7-methoxymethyl-2-oxo-octahydro-oxazolo[4,5-c]pyridin-5-ium; useful as agents for stimulating the cognitive functions of the brain |
| 02/14/2008 | US20080039464 Compounds Which Modulate The CB2 Receptor |
| 02/14/2008 | US20080039463 Methods and Compositions |
| 02/14/2008 | US20080039462 Compounds having 5-HT6 receptor affinity |
| 02/14/2008 | US20080039461 Treatment of pain by inhibition of p38 map kinase |
| 02/14/2008 | US20080039459 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 02/14/2008 | US20080039458 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/14/2008 | US20080039456 4-[2-(4-nitro-phenyl)-6-oxo-4-thioxo-6H-1-oxa-3b,5-diaza-cyclopenta[a]pentalen-5-yl]-butyric acid, used for inhibiting heparin-binding proteins and in the treatment of pancreatic cancer; anticarcinogenic agents |
| 02/14/2008 | US20080039454 Urotensin II receptor antagonists |
| 02/14/2008 | US20080039451 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 02/14/2008 | US20080039450 Compounds |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039446 Substituted isoindoles and their use |
| 02/14/2008 | US20080039443 Manipulation of brain CDP-diacylglycerol and uses thereof |
| 02/14/2008 | US20080039442 Compounds With Kv4 Ion Channel Activity |
| 02/14/2008 | US20080039441 Storage stability; combination forms with antidepressants, antiinflammatories, serotonin reuptake inhibitors, antiemetics, appetite modulators, antivirals, vasodilators and/or pain relievers |
| 02/14/2008 | US20080039439 Alpha2C adrenoreceptor agonists |
| 02/14/2008 | US20080039406 3,6-bridged tylosin derivatives |
| 02/14/2008 | US20080039404 Bifunctional analgesic compounds for opioid receptor agonists and neurokinin-1 receptor antagonists |
| 02/14/2008 | US20080039385 Neublastin Variants |
| 02/14/2008 | US20080039364 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 02/14/2008 | US20080038363 Aerosol delivery system and uses thereof |
| 02/14/2008 | US20080038357 Inhalation Powder Containing the CGRP antagonist BIBN4096 and Process for the Preparation Thereof |
| 02/14/2008 | US20080038348 Modified release formulations of a bupropion salt |
| 02/14/2008 | US20080038346 Extended release tablet formulations of flibanserin and method for manufacturing the same |
| 02/14/2008 | US20080038345 Microparticles having osmotic subcoat; extended release tablets; shelf life; hydrobromide form |
| 02/14/2008 | US20080038331 Enantiomerically pure S-etifoxine, pharmaceutical compositions thereof and methods of their use |
| 02/14/2008 | US20080038309 Use of polypeptides obtained through systematic mutations of single amino acids of human and non-human Box-A of HMGB1 to prevent and/or antagonize pathologies induced by HMGB1 |
| 02/14/2008 | US20080038291 Method to reduce the physiologic effects of drugs on mammals |
| 02/14/2008 | US20080038279 Composition For Treating Pathology Associated With Msrv/Herv-W |
| 02/14/2008 | US20080038275 Method for the treatment of multiple sclerosis |
| 02/14/2008 | US20080038264 Compositions and methods for the treatment of immune related diseases |
| 02/14/2008 | US20080038249 Treatment Of Neurodegenerative Diseases By The Use Of Laptm4a |
| 02/14/2008 | US20080038247 Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39) |
| 02/14/2008 | US20080038237 Trojan horse immunotherapy |
| 02/14/2008 | US20080038209 Nicotine Delivery Product and Method for Producing It |
| 02/14/2008 | US20080038198 Method Of Screening Molecule Associated With Psychiatric Disorder |
| 02/14/2008 | DE102006037495A1 Use of substances with pharmacological action e.g. xenon for producing a preparation, in which components of the preparation are a gas or a lightly volatile fluid, for administration of the substances to humans or animals over the eyes |
| 02/14/2008 | CA2675243A1 Milnacipran for the treatment of fatigue associated with fibromyalgia syndrome |
| 02/14/2008 | CA2660689A1 Spinal nerve repair promoting therapeutics containing des-acyl ghrelin or its derivatives as an active ingredient |
| 02/14/2008 | CA2660517A1 Spinal nerve repair promoting therapeutics containing ghrelin or its derivatives or substances that act on ghs-rla as an active ingredient |
| 02/14/2008 | CA2660421A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 02/14/2008 | CA2660349A1 2-aminobenzoxazole carboxamides as 5ht3 modulators |
| 02/14/2008 | CA2660330A1 Novel monoclonal antibody and use of the same |
| 02/14/2008 | CA2659967A1 Quinazoline derivatives |
| 02/14/2008 | CA2659599A1 Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
| 02/14/2008 | CA2659598A1 Amino phosphate derivative and s1p receptor modulator having same as an active ingredient |
| 02/14/2008 | CA2659295A1 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 02/14/2008 | CA2659162A1 Eucalyptus extract, method of preparation and therapeutic uses thereof |
| 02/14/2008 | CA2658614A1 Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination |
| 02/14/2008 | CA2658589A1 Mono-and divalent salts of n-(5-hydroxynicotinoil)-l-glutaminic acid exhibiting psychotropic (antidepressant and anxiolytic), neuroprotective, heroprotective and cerebroprotectiveaction |
| 02/13/2008 | EP1887016A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
| 02/13/2008 | EP1887008A1 Thienotriazolodiazepine compound and a medicinal use thereof |
| 02/13/2008 | EP1887000A1 Arylacetate derivative having isoxazole skeleton |
| 02/13/2008 | EP1886996A1 1H-Quinolin-4-one compounds, with affinity for the GABA receptor, processes, uses and compositions |
| 02/13/2008 | EP1886993A1 Benzo[f]isoindole derivatives with affinity to the ep4 receptor |
| 02/13/2008 | EP1886990A1 Phenyl-prenyl-ether derivatives for the treatment of cognitive neurodegenerative or neuronal diseases or disorders |
| 02/13/2008 | EP1886693A1 Agent for regeneration and/or protection of nerves |
| 02/13/2008 | EP1886681A2 New nuclear transcription factors regulators |
| 02/13/2008 | EP1886678A1 Stable tablet containing droxidopa |
| 02/13/2008 | EP1885863A2 Methods for delivering genes |
| 02/13/2008 | EP1885716A1 Thiazole derivatives and use thereof |
| 02/13/2008 | EP1885709A2 Benzofuran derivatives with therapeutic activities |
| 02/13/2008 | EP1885699A1 Crystalline form of benzazepinium maleate derivative |
| 02/13/2008 | EP1885694A2 4-biarylyl-1-phenylazetidin-2-ones |